Basic's Support for Agentic RAG in Pharmaceutical Development
In the November 2025 issue of
PHARM TECH JAPAN, an insightful article written by Ryota Kimata from
Sawai Pharmaceutical Co., Ltd., is featured. This article discusses the incorporation of digital transformation (DX) strategies in pharmaceutical development, emphasizing the collaboration between Basic Co., Ltd. and Sawai Pharmaceutical. Here, we delve deeper into the content and implications of this significant collaboration.
Overview of the Article
The article titled **